Aviva plc (LON:AV)
London · Delayed Price · Currency is GBP · Price in GBX 641.80
-1.40 (-0.22%)
Feb 19, 2026, 2:04 PM GMT
Aviva Revenue
Aviva had revenue of 12.37B GBP in the half year ending June 30, 2025, with 26.53% growth. This brings the company's revenue in the last twelve months to 24.26B, up 7.10% year-over-year. In the year 2024, Aviva had annual revenue of 22.74B with 5.36% growth.
Revenue (ttm)
24.26B
Revenue Growth
+7.10%
P/S Ratio
0.81
Revenue / Employee
833.97K
Employees
29,091
Market Cap
19.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.74B | 1.16B | 5.36% |
| Dec 31, 2023 | 21.58B | 5.38B | 33.20% |
| Dec 31, 2022 | 16.20B | -459.00M | -2.75% |
| Dec 31, 2021 | 16.66B | -9.18B | -35.53% |
| Dec 31, 2020 | 25.84B | -17.11B | -39.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 43.13B |
| Barclays | 26.82B |
| Lloyds Banking Group | 18.62B |
| NatWest Group | 15.97B |
| Standard Chartered | 15.00B |
| Legal & General Group | 12.45B |
| Prudential | 9.74B |
| London Stock Exchange Group | 9.14B |
Aviva News
- 1 day ago - One in nine new homes in England built in areas of flood risk, study shows - The Guardian
- 7 days ago - Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys - Seeking Alpha
- 7 days ago - Ripple Wins Aviva Deal For XRP Ledger, But XRP Dips Towards $1.30 - Benzinga
- 24 days ago - Aviva Bio Announces FDA Guidance on Development Pathway for Women's Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291 - Business Wire
- 4 weeks ago - The hill I will die on: Stag and hen dos should be fun, not bankrupting endurance tests | Liam Pape - The Guardian
- 5 weeks ago - Leinster v La Rochelle: Old rivalry renewed as Ronan O’Gara’s men visit the Aviva - Independent Ireland
- 6 weeks ago - Aviva-backed altnet Truespeed in merger talks with rival - Sky News
- 6 weeks ago - Aviva Shares Update On Direct Line Capital Model - Nasdaq